Neurosense Therapeutics Ltd. (NRSN)
Market Closed
27 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XFRA $
0. 59
-0.01
-2.4917%
$
20.75M Market Cap
- P/E Ratio
- Div Yield
84,871 Volume
-0.8 Eps
$ 0.6
Previous Close Investors:
Want to track NRSN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neurosense Therapeutics Ltd. (NRSN) Statistics
Valuation metrics
Market Cap 20.75M
Enterprise value 14.86M
Trailing P/E (ttm) -1.35
Forward P/E -
PEG ratio -1.02
Price/Sales (ttm) -
Price/Book (mrq) -9.87
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.34
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 161K
Average volume (90 days) 153.56K
Price summary
52-Week low 0.58
52-Week high 2.09
Beta -
50-Day moving average 0.69
200-Day moving average 0.84
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -10.82%
Return on equity 10.7%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.44
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.01
Total debt (mrq) -
Total Debt/Equity (mrq) -0.11
Current ratio (mrq) 0.31%
Book value per share (mrq) -0.06
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
